2-(Methylamino)-N-phenylacetamide hydrochloride

Catalog No.: 
ACINCB914
CAS No.: 
60565-45-9
Molecular Formula: 
C9H13ClN2O
Molecular Weight: 
200.67
2-(Methylamino)-N-phenylacetamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$130.00InquiryInquiry
100mg95%$186.00InquiryInquiry
250mg95%$393.00InquiryInquiry
1g95%$862.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Methylamino)-N-phenylacetamide hydrochloride
IUPAC Name2-(methylamino)-N-phenylacetamide hydrochloride
MDL No.MFCD10686932
Molecular FormulaC9H13ClN2O
Molecular Weight200.67
SMILESO=C(NC1=CC=CC=C1)CNC.[H]Cl
InChI KeyLTTCXNVKPIYQNV-UHFFFAOYSA-N
Synonym2-(methylamino)-N-phenylacetamide hydrochloride;2-(Methylamino)-N-phenylacetamide monohydrochloride
CAS No.60565-45-9
PubChem CID13706112

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACINCB914 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVRHZ791 route compound structure diagram
    ACVRHZ791587-65-5In Stock
  4. Then
  5. ACINCB914 route product structure diagram
    ACINCB91460565-45-9
Inquiry

2. ACINCB914 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACINCB914 route product structure diagram
    ACINCB91460565-45-9
Inquiry

3. ACINCB914 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACINCB914 route product structure diagram
    ACINCB91460565-45-9
Inquiry

Comments (0)